INTERNATIONAL PATENT: MEDIMMUNE, LLC, AMGEN INC. FILES APPLICATION FOR "TREATMENT OF EOSINOPHILIC ESOPHAGITIS WITH ANTI-TSLP ANTIBODY"

GENEVA, Oct. 28 -- MEDIMMUNE, LLC (One MedImmune WayGaithersburg, MD 20878), AMGEN INC. (One Amgen Center DriveThousand Oaks, CA 91320-1799) filed a patent application (PCT/US2025/025157) for "TREATMENT OF EOSINOPHILIC ESOPHAGITIS WITH ANTI-TSLP ANTIBODY" on Apr 17, 2025. With publication no. WO/2025/221995, the details related to the patent application was published on Oct 23, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SHERRILL, Joseph (c/o MedImmune, LLCOne MedImmune WayGaithersburg, MD 20878), CAVENEY, Scott (c/o Amgen Inc.One Amgen Center Drive, Mail Stop 28-5-AThousand Oaks, CA 913...